|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on April 15, 2003
Accepted on October 21, 2003
Molecular Diagnostics and Genetics |
1 University Medical Center Nijmegen, Laboratory of Pediatrics and Neurology, NL-6500 HB Nijmegen, The Netherlands
2 Ghent University School of Medicine, Departments of Pediatrics and Medical Genetics, Ghent, Belgium
3 University Medical Center Nijmegen, Department of Pediatrics, NL-6500 HB Nijmegen, The Netherlands
* To whom correspondence should be addressed. E-mail: r.wevers{at}cukz.umcn.nl.
Background: There is no comprehensive analytical technique to analyze N-acetylated metabolites in urine. Many of these compounds are involved in inborn errors of metabolism. In the present study, we examined the potential of proton nuclear magnetic resonance ($1H-NMR) spectroscopy as a tool to identify and quantify N-acetylated metabolites in urine of patients with various inborn errors of metabolism.
Methods: We performed $1H-NMR spectroscopy on a 500 MHz spectrometer. Using a combination of one- and two-dimensional correlation spectroscopy (COSY) $1H-NMR spectra, we were able to assign and quantify resonances of characteristic N-acetylated compounds products in urine of patients with 13 inborn errors of metabolism.
Results: The disease-specific N-acetylated metabolites were excreted at concentrations >100 µmol/mmol of creatinine in the patients urine. In control urine samples, the concentration of individual N-acetyl-containing compounds was <40 µmol/mmol of creatinine. The combination of one- and two-dimensional COSY NMR spectroscopy led to the correct diagnosis of nine different inborn errors of metabolism. No abnormalities were observed in the spectra of urine from patients with G$1- or G$1-gangliosidosis. We also determined the $1H-NMR characteristics of N-acetylated metabolites that may be relevant to human metabolism.
Conclusion: $1H-NMR spectroscopy may be used to identify and quantify N-acetylated metabolites of diagnostic importance for the field of inborn errors of metabolism.© 2004 American Association for Clinical Chemistry
The following articles in journals at HighWire Press have cited this article:
![]() |
S. B. Wortmann, R. J. T. Rodenburg, A. Jonckheere, M. C. de Vries, M. Huizing, K. Heldt, L. P. van den Heuvel, U. Wendel, L. A. Kluijtmans, U. F. Engelke, et al. Biochemical and genetic analysis of 3-methylglutaconic aciduria type IV: a diagnostic strategy Brain, January 1, 2009; 132(1): 136 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shanaiah, M. A. Desilva, G. A. Nagana Gowda, M. A. Raftery, B. E. Hainline, and D. Raftery Class selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR PNAS, July 10, 2007; 104(28): 11540 - 11544. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hunt If It Smells Like a Duck, It Might Be an Asthma Subphenotype Am. J. Respir. Crit. Care Med., May 15, 2007; 175(10): 975 - 976. [Full Text] [PDF] |
||||
![]() |
M. Oostendorp, U. F.H. Engelke, M. A.A.P. Willemsen, and R. A. Wevers Diagnosing Inborn Errors of Lipid Metabolism with Proton Nuclear Magnetic Resonance Spectroscopy Clin. Chem., July 1, 2006; 52(7): 1395 - 1405. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |